Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression

Retraction Note: Journal of Hematology & Oncology (2020) 13:24 10.1186/s13045-020-00857-7

The Editor-in-Chief has retracted this article. After publication, concerns were raised about image reuse in the article. Specifically:

The top-left panel of Fig. 2F was reproduced in two panels of Fig. 4H, and in Fig. S11E of the supplementary materials.

There is overlap between the top-left panel of Fig. 2G and the second-from-top-right panel of Fig. 4I.

There is overlap between the top-left panel of Fig. 4I and the bottom-left panel of Fig. 5G.

There is overlap between the second-from-bottom-left panel of Fig. 4I and the top-right panel of Fig. 5G.

There is overlap between the bottom middle panel of Fig. 5G and the bottom-right panel of Fig. S7B of the supplementary materials.

Additionally, the top-left panel of Fig. 2F was found to have previously been published in [1] by some of the same authors. The Editor-in-Chief no longer has confidence in the data reported in the article.

Qiangsong Tong has stated on behalf of all authors that they do not agree to this retraction.